| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.17 | 0.002 |